Hemophagocytic Syndrome in a Patient with ALL: Morphology Still Matters

We report a case of a young patient suffering from very-high risk B-acute lymphoblastic leukemia (ALL) refractory to first-line therapy with early central nervous system relapse, sequentially treated with inotuzumab. At this timepoint, the patient showed persistent transfusion-refractory thrombocyto...

Full description

Bibliographic Details
Main Authors: Andrea Duminuco, Giuseppe A. M. Palumbo, Bruno Garibaldi, Rosario Foti, Francesco Di Raimondo, Cinzia Maugeri, Elisa Mauro, Paolo F. Fiumara, Calogero Vetro
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Hemato
Subjects:
Online Access:https://www.mdpi.com/2673-6357/2/2/20